Literature DB >> 18281713

Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?

Mariana Bendlin Calzavara1, Wladimir Agostini Medrano, Raquel Levin, Sonia Regina Kameda, Monica Levy Andersen, Sergio Tufik, Regina Helena Silva, Roberto Frussa-Filho, Vanessa Costhek Abílio.   

Abstract

Schizophrenia, bipolar disorder, and attention deficit/hyperactivity disorder (ADHD) present abnormalities in emotion processing. A previous study showed that the spontaneously hypertensive rats (SHR), a putative animal model of ADHD, present reduced contextual fear conditioning (CFC). The aim of the present study was to characterize the deficit in CFC presented by SHR. Adult male normotensive Wistar rats and SHR were submitted to the CFC task. Sensitivity of the animals to the shock and the CFC performance after repeated exposure to the task were investigated. Pharmacological characterization consisted in the evaluation of the effects of the following drugs administered previously to the acquisition of the CFC: pentylenetetrazole (anxiogenic) and chlordiazepoxide (anxiolytic); methylphenidate and amphetamine (used for ADHD); lamotrigine, carbamazepine, and valproic acid (mood stabilizers); haloperidol, ziprasidone, risperidone, amisulpride, and clozapine (neuroleptic drugs); metoclopramide and SCH 23390 (dopamine antagonists without antipsychotic properties); and ketamine (a psychotomimmetic). The effects of paradoxical sleep deprivation (that worsens psychotic symptoms) and the performance in a latent inhibition protocol (an animal model of schizophrenia) were also verified. No differences in the sensitivity to the shock were observed. The repeated exposure to the CFC task did not modify the deficit in CFC presented by SHR. Considering pharmacological treatments, only the neuroleptic drugs reversed this deficit. This deficit was potentiated by proschizophrenia manipulations. Finally, a deficit in latent inhibition was also presented by SHR. These findings suggest that the deficit in CFC presented by SHR could be a useful animal model to study abnormalities in emotional context processing related to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281713      PMCID: PMC2696367          DOI: 10.1093/schbul/sbn006

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  73 in total

Review 1.  The pharmacology of latent inhibition as an animal model of schizophrenia.

Authors:  P C Moser; J M Hitchcock; S Lister; P M Moran
Journal:  Brain Res Brain Res Rev       Date:  2000-09

2.  Paradoxical sleep deprivation in female rats alters drug-induced behaviors.

Authors:  D C Hipólide; S Tufik
Journal:  Physiol Behav       Date:  1995-06

3.  Strain differences in fear between spontaneously hypertensive and normotensive rats.

Authors:  J E Ledoux; A Sakaguchi; D J Reis
Journal:  Brain Res       Date:  1983-10-24       Impact factor: 3.252

Review 4.  The schizophrenic experience: taken out of context?

Authors:  David R Hemsley
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

5.  Brainstem noradrenergic control of nociception is abnormal in the spontaneously hypertensive rat.

Authors:  B K Taylor; R E Roderick; A I Basbaum
Journal:  Neurosci Lett       Date:  2000-09-22       Impact factor: 3.046

Review 6.  Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?

Authors:  André Aleman; René S Kahn
Journal:  Prog Neurobiol       Date:  2005-12-13       Impact factor: 11.685

7.  Amphetamine psychosis and psychotic symptoms.

Authors:  D S Janowsky; C Risch
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

8.  The effects of dopaminergic agonists on genital reflexes in paradoxical sleep-deprived male rats.

Authors:  Monica L Andersen; Sergio Tufik
Journal:  Physiol Behav       Date:  2004-12-19

Review 9.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

10.  Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.

Authors:  Jean-Charles Bizot; Nicolas Chenault; Bérengère Houzé; Alexandre Herpin; Sabrina David; Stéphanie Pothion; Fabrice Trovero
Journal:  Psychopharmacology (Berl)       Date:  2007-04-04       Impact factor: 4.415

View more
  21 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Authors:  Mariana C Diana; Fernanda F Peres; Veronica Justi; Rodrigo A Bressan; Acioly L T Lacerda; José Alexandre Crippa; Jaime E C Hallak; Vanesssa Costhek Abilio
Journal:  CNS Neurosci Ther       Date:  2018-04-14       Impact factor: 5.243

3.  Set shifting in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  Amy C Chess; Brittany E Raymond; Ira G Gardner-Morse; Mark R Stefani; John T Green
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

4.  Hyperactivity, startle reactivity and cell-proliferation deficits are resistant to chronic lithium treatment in adult Nr2e1(frc/frc) mice.

Authors:  B K Y Wong; S M Hossain; E Trinh; G A Ottmann; S Budaghzadeh; Q Y Zheng; E M Simpson
Journal:  Genes Brain Behav       Date:  2010-06-21       Impact factor: 3.449

5.  Persistent cognitive and morphological alterations induced by repeated exposure of adolescent rats to the abused inhalant toluene.

Authors:  K M Braunscheidel; J T Gass; P J Mulholland; S B Floresco; J J Woodward
Journal:  Neurobiol Learn Mem       Date:  2017-07-15       Impact factor: 2.877

6.  The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats.

Authors:  Allison L McIntosh; Theresa M Ballard; Lucinda J Steward; Paula M Moran; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2013-02-09       Impact factor: 4.530

7.  Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.

Authors:  Laura C Amann; Tobias B Halene; Richard S Ehrlichman; Stephen N Luminais; Nan Ma; Ted Abel; Steven J Siegel
Journal:  Neurobiol Dis       Date:  2009-05-23       Impact factor: 5.996

8.  Dopamine D1-like receptor signalling in the hippocampus and amygdala modulates the acquisition of contextual fear conditioning.

Authors:  Florence C Heath; Regimantas Jurkus; Tobias Bast; Marie A Pezze; Jonathan L C Lee; J Peter Voigt; Carl W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2015-03-07       Impact factor: 4.530

9.  Microinjection of valproic acid into the ventrolateral orbital cortex enhances stress-related memory formation.

Authors:  Yan Zhao; Bo Xing; Yong-hui Dang; Chao-ling Qu; Feng Zhu; Chun-xia Yan
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

Review 10.  Experimental sleep deprivation as a tool to test memory deficits in rodents.

Authors:  Valeria Colavito; Paolo F Fabene; Gigliola Grassi-Zucconi; Fabien Pifferi; Yves Lamberty; Marina Bentivoglio; Giuseppe Bertini
Journal:  Front Syst Neurosci       Date:  2013-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.